Abiopharma

Ceasing to be a substantial holder

Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: June Shipment, Sales and Deliveries Hit 242 units, Company Plans to Raise Yearly Shipment Target to 2,000 Units and Becomes the “Star of the Show” at the Automate Conference

Events and transactions

BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve paediatric patients with hypophosphatasia at week 25 in MULBERRY Phase II

Events and transactions

Events and transactions

DXC Investors Have Opportunity to Join DXC Technology Company Fraud Investigation with the Schall Law Firm

MSTR Investors Have Opportunity to Join Strategy Inc Fraud Investigation with the Schall Law Firm

GDS Investors Have Opportunity to Join GDS Holdings Limited Fraud Investigation with the Schall Law Firm